All In Biotech

Drug Trial Radar · NCT03447262

A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy

A Phase 3, Open-label Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation

Last checked: Nov 19, 2026Latest source record: Jan 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

484

Actual

Start

Jul 13, 2018

Primary completion

Sep 9, 2020

Study completion Sep 9, 2020

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Feb 27, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long-term safety and tolerability of VX-659 in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic fibrosis (CF) who are homozygous or heterozygous for the F508del mutation.

Conditions

  • Cystic Fibrosis

Interventions

  • VX-659/TEZ/IVADrug

    Fixed-dose combination tablets for oral administration qd in the morning.

  • IVADrug

    IVA tablet qd in the evening.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)Time frame: From Day 1 up to 28 Days After Last Dose of Study Drug or to the Completion of Study Participation Date, Whichever Occurs First in the Current Study 659-105 (up to Week 100)

Locations

100 sites in 11 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Stanford University

    Palo Alto, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • Hartford Hospital

    Hartford, Connecticut

  • Yale New Haven Medical Center

    New Haven, Connecticut

  • University of Miami Miller School of Medicine

    Miami, Florida

  • Nicklaus Children's Hospital

    Miami, Florida

  • Orlando Health, Inc.- Arnold Palmer Hospital for Children (APH)

    Orlando, Florida

  • Johns Hopkins All Children's Hospital Outpatient Care Center

    St. Petersburg, Florida

  • St. Luke's CF Center of Idaho

    Boise, Idaho

  • Cystic Fibrosis Center of Chicago

    Glenview, Illinois

  • Advocate Children's Hospital - Park Ridge / North Suburban Pulmonary and Critical Care Consultants

    Niles, Illinois

  • Indiana Clinical Research Center, IU Health University Hospital

    Indianapolis, Indiana

  • The University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • University of Kentucky

    Lexington, Kentucky

  • Kosair Charities Pediatric Clinical Research Unit

    Louisville, Kentucky

  • Johns Hopkins Hospital

    Baltimore, Maryland

  • Boston Children's Hospital

    Boston, Massachusetts

  • UMass Memorial Medical Center

    Worcester, Massachusetts

  • Michigan Medicine

    Ann Arbor, Michigan

  • Spectrum Health Medical Group Adult Cystic Fibrosis Care Center

    Grand Rapids, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • The Children's Mercy Hospital

    Kansas City, Missouri

  • Washington University School of Medicine/ St. Louis Children's Hospital

    St Louis, Missouri

  • Dartmouth Hitchcock, Manchester

    Manchester, New Hampshire

  • Rutgers-Robert Wood Johnson Medical School

    New Brunswick, New Jersey

  • Albany Medical College

    Albany, New York

  • CF Therapeutics Development Center of Western New York

    Buffalo, New York

  • Northwell Health, Long Island Jewish Medical Center

    New Hyde Park, New York

  • Columbia University Medical Center

    New York, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Clinical Research of Charlotte

    Charlotte, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • Cincinnati Children's Hospital

    Cincinnati, Ohio

  • Santiago Reyes, M.D.

    Oklahoma City, Oklahoma

  • Oregon Health & Science University

    Portland, Oregon

  • Drexel University College of Medicine / Drexel Adult Cystic Fibrosis Center

    Philadelphia, Pennsylvania

  • Children's Hospital of Pittsburgh of UPMC

    Pittsburgh, Pennsylvania

  • Sanford Children's Specialty Clinic

    Sioux Falls, South Dakota

Showing 40 of 100 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.